Squarepoint Ops LLC Lexicon Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$93.7 Billion
Q2 2025

A detailed history of Squarepoint Ops LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 95,617 shares of LXRX stock, worth $136,732. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,617

Previous 195,409 51.07%

Holding current value

$136,732

Previous $89,000 1.12%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 27, 2025	SELL	$0.42 - $0.95 $41,912 - $94,802	-99,792 Reduced 51.07%	95,617 $90,000
Q2 2025 Aug 14, 2025	SELL	$0.42 - $0.95 $41,912 - $94,802	-99,792 Reduced 51.07%	95,617 $90,000
Q1 2025 Aug 27, 2025	BUY	$0.29 - $0.96 $28,939 - $95,800	99,792 Added 104.37%	195,409 $89,000
Q1 2025 May 15, 2025	BUY	$0.29 - $0.96 $56,668 - $187,592	195,409 New	195,409 $89,000
Q3 2024 Nov 14, 2024	BUY	$1.51 - $2.39 $285,151 - $451,332	188,842 New	188,842 $296,000
Q1 2023 May 15, 2023	SELL	$1.99 - $2.68 $6,618 - $8,913	-3,326 Reduced 12.2%	23,938 $58,000
Q4 2022 Feb 14, 2023	BUY	$1.8 - $2.56 $49,075 - $69,795	27,264 New	27,264 $52,000
Q2 2022 Aug 15, 2022	SELL	$1.31 - $2.69 $34,307 - $70,448	-26,189 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $24,523 - $48,920	-12,576 Reduced 32.44%	26,189 $55,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $100,778 - $162,938	26,451 Added 214.8%	38,765 $153,000
Q3 2021 Nov 15, 2021	SELL	$3.38 - $5.35 $1,480 - $2,343	-438 Reduced 3.43%	12,314 $59,000
Q2 2021 Aug 16, 2021	SELL	$4.12 - $5.87 $307,949 - $438,753	-74,745 Reduced 85.43%	12,752 $59,000
Q1 2021 May 17, 2021	BUY	$3.45 - $9.09 $247,910 - $653,189	71,858 Added 459.48%	87,497 $514,000
Q4 2020 Feb 16, 2021	SELL	$1.05 - $3.67 $160,140 - $559,730	-152,515 Reduced 90.7%	15,639 $53,000
Q3 2020 Nov 16, 2020	BUY	$1.44 - $2.1 $42,104 - $61,401	29,239 Added 21.05%	168,154 $242,000
Q2 2020 Aug 14, 2020	SELL	$1.75 - $2.3 $214,574 - $282,012	-122,614 Reduced 46.88%	138,915 $277,000
Q1 2020 May 15, 2020	BUY	$1.8 - $4.28 $280,152 - $666,139	155,640 Added 146.98%	261,529 $510,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $5.15 $334,609 - $545,328	105,889 New	105,889 $439,000
Q3 2019 Nov 14, 2019	SELL	$1.2 - $6.66 $65,998 - $366,293	-54,999 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$5.35 - $7.11 $105,148 - $139,739	-19,654 Reduced 26.33%	54,999 $346,000
Q1 2019 May 15, 2019	BUY	$4.36 - $7.94 $212,157 - $386,360	48,660 Added 187.2%	74,653 $415,000
Q4 2018 Feb 14, 2019	BUY	$6.15 - $10.51 $159,856 - $273,186	25,993 New	25,993 $173,000
Q2 2018 Aug 14, 2018	SELL	$7.8 - $13.69 $155,438 - $272,814	-19,928 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$7.86 - $11.39 $156,634 - $226,979	19,928 New	19,928 $171,000
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $127,656 - $178,747	-14,556 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $177,146 - $237,262	14,556	14,556 $179,000

Others Institutions Holding LXRX

# of Institutions

129

Shares Held

226M

Call Options Held

431K

Put Options Held

138K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $270M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Lexicon Pharmaceuticals, Inc. Transaction History